Dr. Contreras is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1611 NW 12th Ave
# M851
Miami, FL 33136Phone+1 305-585-1111Fax+1 305-243-8470
Summary
- I earned my medical degree in 1984 from the Autonomous University of Guadalajara in Mexico. I trained in Internal medicine, nephrology, hypertension, critical care, and earned a degree as Master in Public Health between 1989 and 2003. In 1996, I joined the School of Medicine at the University of Miami. During my time as faculty in the Department of Medicine, I have been involved in the development and establishment of a successful clinical research program in the Division of Nephrology with the accrual of 24 research grants, more than 100 publications in peer review Journals and textbooks. I have an ongoing commitment to improving kidney disease outcomes among racial and ethnic minorities throughout the clinical research program at the University of Miami, Miller School of Medicine.
Education & Training
- University of Miami/Jackson Health SystemFellowship, Critical Care Medicine (Internal Medicine), 1994 - 1996
- University of Miami/Jackson Health SystemFellowship, Nephrology, 1992 - 1994
- Harlem Hospital CenterResidency, Internal Medicine, 1989 - 1992
- Universidad Autonoma de GuadalajaraClass of 1987
Certifications & Licensure
- FL State Medical License 1993 - 2026
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- Super Doctor SuperDoctors.com
Clinical Trials
- African American Study of Kidney Disease and Hypertension ABPM Pilot Study Start of enrollment: 2007 Nov 01
- Nephrotic Syndrome Study Network Start of enrollment: 2010 Apr 01
- Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) Start of enrollment: 2013 Nov 20
Publications & Presentations
PubMed
- 241 citationsDesign of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approachCrystal A. Gadegbeku, Debbie S. Gipson, Lawrence B. Holzman, Akinlolu O. Ojo, Peter X.-K. Song
Kidney International. 2013-04-01 - 131 citationsMast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in miceMehmet M. Altintas, Adiba Azad, Behzad Nayer, Gabriel Contreras, Julia Zaias
Journal of Lipid Research. 2011-03-01 - 69 citationsCureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular DiseaseLaura H. Mariani, Andrew S. Bomback, Pietro A. Canetta, Michael F. Flessner, Margaret E. Helmuth
American Journal of Kidney Diseases. 2019-02-01
Press Mentions
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus NephritisSeptember 17th, 2020
- Statins plus Intensive SBP Control May up Survival in Nondiabetic CKDApril 3rd, 2019
- Cinacalcet as Rescue Therapy for Refractory Hyperparathyroidism in Young Children with Advanced Chronic Kidney DiseaseSeptember 10th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: